Data / Drug companies / Guaifenesin, phenylephrine hcl
Guaifenesin, phenylephrine hcl: 4 companies and 5 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Guaifenesin, phenylephrine hcl is listed in the FDA National Drug Code Directory by 4 companies, with 5 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet; solution/ drops, and the newest product started marketing on May 5, 2022.
The request: Get every company that lists guaifenesin, phenylephrine hcl in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 4
- Products
- 5
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Oral
- Brand names
- Tusnel Pediatric Drops, Mucus Relief Pe, Mucus Relief Pe Sinus Congestion, Giltuss Sinus and Chest Congestion, Gilphex
- openFDA record search
- api.fda.gov
Companies that list guaifenesin, phenylephrine hcl
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Gil Pharmaceutical Corp | 2 | tablet | Over the counter monograph drugs | May 5, 2022 |
| Cardinal Health 110, LLC. DBA Leader | 1 | tablet, film coated | Over the counter monograph drugs | April 15, 2006 |
| Llorens Pharmaceutical International Division, Inc. | 1 | solution/ drops | Over the counter monograph drugs | August 1, 2019 |
| Walgreen Company | 1 | tablet, film coated | Over the counter monograph drugs | April 15, 2006 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 2 | 40% |
| Tablet | 2 | 40% |
| Solution/ drops | 1 | 20% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 5 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Expectorant | 5 |
| alpha-1 Adrenergic Agonist | 5 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.